ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Internal Medicine

Top Internal Medicine Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ANDREW FISCHER M.D.

Internal Medicine

808

$139K

120
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

74%
prescriptions for brand name drugs

Avg: 25%

$172
Average prescription price

Avg: $61

LISA HARRIS MD

Internal Medicine

823

$46.5K

43
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $61

CHRISTOPHER HOFELICH D.O.

Internal Medicine

827

$45.8K

136
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $61

EROMONSELE IDAHOSA MD

Internal Medicine

842

$90.8K

71
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

39%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 25%

$108
Average prescription price

Avg: $61

DANIEL COMBS M.D.

Internal Medicine

853

$34.6K

91
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$41
Average prescription price

Avg: $61

KARLA MARQUEZ SALAZAR M.D.

Internal Medicine

858

$70.1K

77
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

14%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$82
Average prescription price

Avg: $61

MALAR RAMASAMY MD

Internal Medicine

860

$40.1K

67
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $61

JISHU DAS MD

Internal Medicine

877

$49.7K

74
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $61

BURKE MAMLIN MD

Internal Medicine

883

$35.6K

67
33 are 65+

21%
patients receiving schedule two controlled substances

Avg: 6%

30%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$40
Average prescription price

Avg: $61

MARK PIERCE M.D.

Internal Medicine

892

$70.6K

59
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$79
Average prescription price

Avg: $61

EMILY YOUNG MD

Internal Medicine

895

$34.6K

122
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$39
Average prescription price

Avg: $61

DAVID HARDIN MD

Internal Medicine

920

$47.5K

120
68 are 65+

23%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $61

SUNIL PATEL

Internal Medicine

933

$43.4K

195
157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $61

RAJ VUPPALANCHI M.D.

Internal Medicine

934

$735K

167
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 25%

$787
Average prescription price

Avg: $61

SOHAIL USMAN MD

Internal Medicine

947

$98.2K

132
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$104
Average prescription price

Avg: $61

TARANGINI PADHYA MD

Internal Medicine

947

$44.9K

79
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $61

SHELAGH FRASER MD

Internal Medicine

949

$80.8K

34
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 25%

$85
Average prescription price

Avg: $61

JONI MILLER MD

Internal Medicine

950

$48.5K

140
114 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $61

STANLEY REED MD

Internal Medicine

951

$56.8K

20
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $61

MARY ELLEN MASLEID M.D.

Internal Medicine

953

$66.5K

152
96 are 65+

13%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$70
Average prescription price

Avg: $61

RACQUEL REYES M.D.

Internal Medicine

989

$39.8K

44
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$40
Average prescription price

Avg: $61

JORGE MEDINA MD

Internal Medicine

1,014

$75.4K

99
67 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$74
Average prescription price

Avg: $61

JOHN DECELLES M.D.

Internal Medicine

1,031

$68K

238
208 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$66
Average prescription price

Avg: $61

ABEL KHO

Internal Medicine

1,032

$63.4K

70
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $61

ANTOINETTE MENSAH MD

Internal Medicine

1,052

$119K

144
96 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

0%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 25%

$113
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank